NCT00918411View on ClinicalTrials.gov

A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Ramosetron

oral

DRUG

Placebo

oral

Trial Locations (4)

Unknown

Hokkaido

Kansai

Kantou

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00918411 - A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter